Rombotis Spiro George - Insider Non-Derivative Transactions at Cyclacel Pharmaceuticals, Inc. (CYCC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 21, 2023, Rombotis Spiro George's relationship to Cyclacel Pharmaceuticals, Inc. (CYCC) is Director,Officer (President and CEO), and currently has 68,658 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYCC insiders.
Data Source: SEC.
Rombotis Spiro George - Insider Non-Derivative Transactions of CYCC Common Stock
Rombotis Spiro George - Insider Non-Derivative Transactions at CYCC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 22, 2023 | P -- (Common Stock) | 6070 | 3.32 | 68658 |
| Feb 1, 2023 | Acquisition -- (Common Stock) | 57600 | 0 | 62588 |